Study of recombinant human tissue factor pathway inhibitor (rhTFPI) solubil
ity shows (1) an inverted bell-shaped pH-solubility profile with a broad so
lubility minimum between pH 5 and 10 such that the solubility minimum midpo
int is 2-3 pH units away from its isoelectric point; (2) a negative tempera
ture-solubility coefficient; (3) a strong dependence of solubility on the v
alence of electrolytes, with both multivalent cations and anions enhancing
this effect; and (4) a significant increase of solubility in the presence o
f charged polymers. At pH 6-7, rhTFPI solubility-salt profiles display typi
cal salting-in and salting-out biphasic effects. At a slightly lower pH (pH
5), a third phase in addition to the salting-in and salting-out phases was
observed at low ionic strength conditions (5 to 50 mM) where rhTFPI solubi
lity increased as salt concentration decreased. The salting-out constant fo
r rhTFPI in NaCl is 1.04 M-1 and is independent of the pH of the solution.
Resolubilization of rhTFPI precipitates revealed that "insolubitity precipi
tates" (seen during buffer exchanges) resulted from protein solute saturati
on and could be redissolved by "native" solvent conditions. On the other ha
nd, "instability precipitates" (typically seen after exposure to elevated t
emperatures or extended storage periods) were caused by insoluble protein a
ggregate formation and required strongly denaturing conditions to redissolv
e.